Metformin access and affordability
Pro Research Analysisby 
Searched over 200M research papers
Global Metformin Access: Availability in High-, Middle-, and Low-Income Countries
Metformin, a key medication for type 2 diabetes, is widely available in high-income countries, with 100% of surveyed pharmacies stocking it. However, its availability drops in lower-income settings: 88.2% in upper-middle-income, 86.1% in lower-middle-income, and only 64.7% in low-income countries (excluding India) . In India, availability remains high at 100% . Similar patterns are observed in other studies, with metformin 500 mg generics showing high mean availability (≥80%) across 17 surveyed countries, but with significant variation by country and region . In Ukraine, domestic production ensures full availability of metformin in the wholesale market, especially for locally manufactured products .
Metformin Affordability: Cost Barriers and Socio-Economic Impact
Affordability of metformin varies greatly by country income level. In high-income countries, only 0.7% of households cannot afford metformin, compared to 26.9% in low-income countries . The cost of a month’s supply of metformin is generally low, but even small costs can be prohibitive for low-income households Chow2018Babar2019. In most surveyed countries, the price of generic metformin is reasonable and affordable for the lowest-paid workers, but affordability is much worse for imported or branded products and in countries with lower purchasing power Babar2019Ryshchenko2022. In Ukraine, locally produced metformin is the most economically justified option for both working-age and retired populations, while foreign-made options are less affordable .
Reimbursement and Policy Measures to Improve Metformin Access
Government reimbursement programs can significantly improve metformin affordability. In Ukraine, metformin is included in the state reimbursement program, with 13 out of 40 metformin products fully reimbursed and others requiring only small co-payments, especially for domestic products . However, foreign-made drugs often require higher co-payments, reducing their affordability . Expanding reimbursement to include more forms of metformin, such as prolonged-release versions, and innovative diabetes drugs could further improve access and outcomes .
Cost-Effectiveness and the Role of Metformin in Diabetes Care
Metformin remains a highly cost-effective diabetes treatment, especially in resource-constrained settings Solini2024Baker2021. Its low cost, proven efficacy, and safety profile make it a preferred first-line therapy for type 2 diabetes in most guidelines Solini2024Baker2021. While newer diabetes medications offer additional benefits for some high-risk patients, their higher costs limit widespread use, making metformin’s affordability a key advantage in many healthcare systems Solini2024Baker2021.
Conclusion
Metformin is generally available and affordable in high-income countries, but significant barriers remain in low- and middle-income countries, where both availability and affordability are lower. Local production, government reimbursement, and the use of generics can improve access, but further policy efforts are needed to ensure equitable access to this essential diabetes medication worldwide Chow2018Babar2019Ryshchenko2022+3 MORE.
Sources and full results
Most relevant research papers on this topic